Deborah J. Heath

1.2k total citations
12 papers, 1.0k citations indexed

About

Deborah J. Heath is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Deborah J. Heath has authored 12 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Hematology and 3 papers in Molecular Biology. Recurrent topics in Deborah J. Heath's work include Multiple Myeloma Research and Treatments (5 papers), Bone health and treatments (4 papers) and Blood properties and coagulation (3 papers). Deborah J. Heath is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Bone health and treatments (4 papers) and Blood properties and coagulation (3 papers). Deborah J. Heath collaborates with scholars based in United Kingdom, United States and Greece. Deborah J. Heath's co-authors include S. Leah Etheridge, Paul G. Genever, Gary J. Spencer, S. Downes, Marcus Textor, Nathalie Bock, Simone C. Rizzi, A.G.A. Coombes, Peter I. Croucher and Αchilles Anagnostopoulos and has published in prestigious journals such as Blood, Biomaterials and Cancer Research.

In The Last Decade

Deborah J. Heath

12 papers receiving 1.0k citations

Peers

Deborah J. Heath
Nunzia Di Maggio Switzerland
Yehezkiel A. Gluzband United States
Duohui Jing Germany
K Stewart United Kingdom
Ming K. Chang Australia
Marilyn A. Baber United States
Deborah J. Heath
Citations per year, relative to Deborah J. Heath Deborah J. Heath (= 1×) peers N. Quirici

Countries citing papers authored by Deborah J. Heath

Since Specialization
Citations

This map shows the geographic impact of Deborah J. Heath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah J. Heath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah J. Heath more than expected).

Fields of papers citing papers by Deborah J. Heath

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah J. Heath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah J. Heath. The network helps show where Deborah J. Heath may publish in the future.

Co-authorship network of co-authors of Deborah J. Heath

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah J. Heath. A scholar is included among the top collaborators of Deborah J. Heath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah J. Heath. Deborah J. Heath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Chantry, Andrew, Deborah J. Heath, Les Coulton, et al.. (2008). P3. A soluble activin type II receptor prevents the development of myeloma bone disease. Cancer Treatment Reviews. 34. 13–14. 1 indexed citations
2.
Heath, Deborah J., Karin Vanderkerken, Xin Cheng, et al.. (2007). An Osteoprotegerin-like Peptidomimetic Inhibits Osteoclastic Bone Resorption and Osteolytic Bone Disease in Myeloma. Cancer Research. 67(1). 202–208. 62 indexed citations
3.
Terpos, Evangelos, Deborah J. Heath, Amin Rahemtulla, et al.. (2006). Bortezomib reduces serum dickkopf‐1 and receptor activator of nuclear factor‐κB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma. British Journal of Haematology. 135(5). 688–692. 170 indexed citations
4.
Politou, Marianna, Deborah J. Heath, Amin Rahemtulla, et al.. (2006). Serum concentrations of Dickkopf‐1 protein are increased in patients with multiple myeloma and reduced after autologous stem cell transplantation. International Journal of Cancer. 119(7). 1728–1731. 123 indexed citations
5.
Terpos, Evangelos, Deborah J. Heath, Amin Rahemtulla, et al.. (2006). Bortezomib Reduces Serum Dickkopf-1 and RANKL Concentrations and Normalizes Indices of Bone Remodeling in Patients with Relapsed Multiple Myeloma.. Blood. 108(11). 506–506. 3 indexed citations
7.
Etheridge, S. Leah, Gary J. Spencer, Deborah J. Heath, & Paul G. Genever. (2004). Expression Profiling and Functional Analysis of Wnt Signaling Mechanisms in Mesenchymal Stem Cells. Stem Cells. 22(5). 849–860. 298 indexed citations
8.
Heath, Deborah J., Paul Christian, & Martin Griffin. (2002). Involvement of tissue transglutaminase in the stabilisation of biomaterial/tissue interfaces important in medical devices. Biomaterials. 23(6). 1519–1526. 35 indexed citations
9.
Rizzi, Simone C., Deborah J. Heath, A.G.A. Coombes, et al.. (2001). Biodegradable polymer/hydroxyapatite composites: Surface analysis and initial attachment of human osteoblasts. Journal of Biomedical Materials Research. 55(4). 475–486. 251 indexed citations
10.
Heath, Deborah J., et al.. (2001). Characterization of Tissue Transglutaminase in Human Osteoblast-like Cells. Journal of Bone and Mineral Research. 16(8). 1477–1485. 43 indexed citations
11.
Verderio, Elisabetta, Allan G.A. Coombes, Richard A. Jones, et al.. (2000). Role of the cross-linking enzyme tissue transglutaminase in the biological recognition of synthetic biodegradable polymers. Journal of Biomedical Materials Research. 54(2). 294–304. 22 indexed citations
12.
Kereiakes, Dean J., et al.. (1984). Sudden death during ambulatory electrocardiographic monitoring: Importance of morphologic confirmation to establish cause of death. The American Journal of Cardiology. 53(9). 1403–1404. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026